3 studies found for:    syn115
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Condition: Parkinson's Disease
Interventions: Drug: Tozadenant (SYN115) 60 mg BID;   Drug: Placebo;   Drug: Levodopa (L-dopa);   Drug: Tozadenant (SYN115) 120 mg BID;   Drug: Tozadenant (SYN115) 180 mg BID;   Drug: Tozadenant (SYN115) 240 mg BID
2 Completed Study to Evaluate SYN115 in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Placebo;   Drug: Tozadenant
3 Completed An fMRI Study of SYN115 in Cocaine Dependent Subjects
Condition: Cocaine Dependence
Interventions: Drug: SYN115;   Drug: PLACEBO

Indicates status has not been verified in more than two years